Paul K. Maciejewski
Cornell University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul K. Maciejewski.
PLOS Medicine | 2009
Holly G. Prigerson; Mardi J. Horowitz; Selby Jacobs; Colin Murray Parkes; Mihaela Aslan; Karl Goodkin; Beverley Raphael; Samuel J. Marwit; Camille B. Wortman; Robert A. Neimeyer; George A. Bonanno; Susan D. Block; David W. Kissane; Paul A. Boelen; Andreas Maercker; Brett T. Litz; Jeffrey G. Johnson; Michael B. First; Paul K. Maciejewski
Holly Prigerson and colleagues tested the psychometric validity of criteria for prolonged grief disorder (PGD) to enhance the detection and care of bereaved individuals at heightened risk of persistent distress and dysfunction.
JAMA Internal Medicine | 2009
Alexi A. Wright; Haiden A. Huskamp; Matthew Nilsson; Matthew L. Maciejewski; Craig C. Earle; Susan D. Block; Paul K. Maciejewski; G Holly Prigerson.
BACKGROUND Life-sustaining medical care of patients with advanced cancer at the end of life (EOL) is costly. Patient-physician discussions about EOL wishes are associated with lower rates of intensive interventions. METHODS Funded by the National Institute of Mental Health and the National Cancer Institute, Coping With Cancer is a longitudinal multi-institutional study of 627 patients with advanced cancer. Patients were interviewed at baseline and were followed up through death. Costs for intensive care unit and hospital stays, hospice care, and life-sustaining procedures (eg, mechanical ventilator use and resuscitation) received in the last week of life were aggregated. Generalized linear models were applied to test for cost differences in EOL care. Propensity score matching was used to reduce selection biases. RESULTS Of 603 participants, 188 (31.2%) reported EOL discussions at baseline. After propensity score matching, the remaining 415 patients did not differ in sociodemographic characteristics, recruitment sites, illness acknowledgment, or treatment preferences. Further analyses, adjusted by quintiles of propensity scores and significant confounders, revealed that the mean (SE) aggregate costs of care (in 2008 US dollars) were
JAMA | 2009
Andrea C. Phelps; Paul K. Maciejewski; Matthew Nilsson; Tracy A. Balboni; Alexi A. Wright; M. Elizabeth Paulk; E. D. Trice; Deborah Schrag; John R. Peteet; Susan D. Block; Holly G. Prigerson
1876 (
Human Brain Mapping | 2008
Vince D. Calhoun; Paul K. Maciejewski; Godfrey D. Pearlson; Kent A. Kiehl
177) for patients who reported EOL discussions compared with
American Journal of Public Health | 2002
Holly G. Prigerson; Paul K. Maciejewski; Robert A. Rosenheck
2917 (
Journal of Nervous and Mental Disease | 2001
Holly G. Prigerson; Paul K. Maciejewski; Robert A. Rosenheck
285) for patients who did not, a cost difference of
Journal of Clinical Oncology | 2008
Alexander K. Smith; Ellen P. McCarthy; Elizabeth Paulk; Tracy A. Balboni; Paul K. Maciejewski; Susan D. Block; Holly G. Prigerson
1041 (35.7% lower among patients who reported EOL discussions) (P =.002). Patients with higher costs had worse quality of death in their final week (Pearson production moment correlation partial r = -0.17, P =.006). CONCLUSIONS Patients with advanced cancer who reported having EOL conversations with physicians had significantly lower health care costs in their final week of life. Higher costs were associated with worse quality of death.
Proceedings of the National Academy of Sciences of the United States of America | 2009
Avis Brennan Hains; Mai Anh T. Vu; Paul K. Maciejewski; Christopher H. van Dyck; Melissa Gottron; Amy F.T. Arnsten
CONTEXT Patients frequently rely on religious faith to cope with cancer, but little is known about the associations between religious coping and the use of intensive life-prolonging care at the end of life. OBJECTIVE To determine the way religious coping relates to the use of intensive life-prolonging end-of-life care among patients with advanced cancer. DESIGN, SETTING, AND PARTICIPANTS A US multisite, prospective, longitudinal cohort of 345 patients with advanced cancer, who were enrolled between January 1, 2003, and August 31, 2007. The Brief RCOPE assessed positive religious coping. Baseline interviews assessed psychosocial and religious/spiritual measures, advance care planning, and end-of-life treatment preferences. Patients were followed up until death, a median of 122 days after baseline assessment. MAIN OUTCOME MEASURES Intensive life-prolonging care, defined as receipt of mechanical ventilation or resuscitation in the last week of life. Analyses were adjusted for demographic factors significantly associated with positive religious coping and any end-of-life outcome at P < .05 (ie, age and race/ethnicity). The main outcome was further adjusted for potential psychosocial confounders (eg, other coping styles, terminal illness acknowledgment, spiritual support, preference for heroics, and advance care planning). RESULTS A high level of positive religious coping at baseline was significantly associated with receipt of mechanical ventilation compared with patients with a low level (11.3% vs 3.6%; adjusted odds ratio [AOR], 2.81 [95% confidence interval {CI}, 1.03-7.69]; P = .04) and intensive life-prolonging care during the last week of life (13.6% vs 4.2%; AOR, 2.90 [95% CI, 1.14-7.35]; P = .03) after adjusting for age and race. In the model that further adjusted for other coping styles, terminal illness acknowledgment, support of spiritual needs, preference for heroics, and advance care planning (do-not-resuscitate order, living will, and health care proxy/durable power of attorney), positive religious coping remained a significant predictor of receiving intensive life-prolonging care near death (AOR, 2.90 [95% CI, 1.07-7.89]; P = .04). CONCLUSIONS Positive religious coping in patients with advanced cancer is associated with receipt of intensive life-prolonging medical care near death. Further research is needed to determine the mechanisms for this association.
Psychological Medicine | 2000
Gabriel K. Silverman; Selby Jacobs; Stanislav V. Kasl; M. K. Shear; Paul K. Maciejewski; F. S. Noaghiul; Holly G. Prigerson
Schizophrenia and bipolar disorder are currently diagnosed on the basis of psychiatric symptoms and longitudinal course. The determination of a reliable, biologically‐based diagnostic indicator of these diseases (a biomarker) could provide the groundwork for developing more rigorous tools for differential diagnosis and treatment assignment. Recently, methods have been used to identify distinct sets of brain regions or “spatial modes” exhibiting temporally coherent brain activity. Using functional magnetic resonance imaging (fMRI) data and a multivariate analysis method, independent component analysis, we combined the temporal lobe and the default modes to discriminate subjects with bipolar disorder, chronic schizophrenia, and healthy controls. Temporal lobe and default mode networks were reliably identified in all participants. Classification results on an independent set of individuals revealed an average sensitivity and specificity of 90 and 95%, respectively. The use of coherent brain networks such as the temporal lobe and default mode networks may provide a more reliable measure of disease state than task‐correlated fMRI activity. A combination of two such hemodynamic brain networks shows promise as a biomarker for schizophrenia and bipolar disorder. Hum Brain Mapp 2008.
Journal of Clinical Oncology | 2009
Elizabeth Trice Loggers; Paul K. Maciejewski; Elizabeth Paulk; Susan DeSanto-Madeya; Matthew Nilsson; Kasisomayajula Viswanath; Alexi A. Wright; Tracy A. Balboni; Jennifer S. Temel; Heather Stieglitz; Susan D. Block; Holly G. Prigerson
OBJECTIVES This study determined the percentage of adverse outcomes in US men attributable to combat exposure. METHODS Standardized psychiatric interviews (modified Diagnostic Interview Schedule and Composite International Diagnostic Interview assessments) were administered to a representative national sample of 2583 men aged 18 to 54 in the National Comorbidity Survey part II subsample. RESULTS Adjusted attributable fraction estimates indicated that the following were significantly attributable to combat exposure: 27.8% of 12-month posttraumatic stress disorder, 7.4% of 12-month major depressive disorder, 8% of 12-month substance abuse disorder, 11.7% of 12-month job loss, 8.9% of current unemployment, 7.8% of current divorce or separation, and 21% of current spouse or partner abuse. CONCLUSIONS Combat exposure results in substantial morbidity lasting decades and accounts for significant and multifarious forms of dysfunction at the national level.